Drug & intervention
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen
RxCUI 2738126
What this record represents
PIN · RxNormThis is an RxNorm PIN drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 MG/MLSCDC · CureCurrent ID 80926
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.12 MG/MLSCDC · CureCurrent ID 80936
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable SuspensionSCD · CureCurrent ID 80928
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML [Fluzone 2026 Southern Hemisphere]SBDC · CureCurrent ID 80930
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.12 MG/ML [Fluzone 2026 Southern Hemisphere]SBDC · CureCurrent ID 80939
influenza A virus A/Singapore/GP20238/2024 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML Injectable Suspension [Fluzone 2026 Southern Hemisphere]SBD · CureCurrent ID 80932
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.